Literature DB >> 27587294

Prevalence and significance of MEFV gene mutations in patients with gouty arthritis.

Ahmet Karaarslan1, Senol Kobak2, Işın Kaya3, Nazım Intepe1, Mehmet Orman4, Afig Berdelı5.   

Abstract

Gouty arthritis is a chronic erosive autoinflammatory disease. Pyrin has anti-inflammatory effects in the regulation of inflammasome and is encoded by the MEFV gene. The relationship between different rheumatic diseases and the MEFV gene mutations was demonstrated. The aim of this study was to determine the frequency of MEFV gene mutations in patients with gouty arthritis and identify a possible correlation with disease phenotype. Ninety-three patients with gouty arthritis and 102 healthy controls, compatible with age, gender and ethnicity, were included in the study. MEFV gene mutations were investigated by PCR method. Out of 93 patients with gouty arthritis, 36 (38.7 %) showed MEFV gene mutations carriage, whereas 20.6 % in healthy control group. Distribution of mutations identified in patients with gouty arthritis was as; R202Q in 18 (19.3 %), E148Q in 5 (5.4 %), K695R in 4 (4.3 %), M680I in 2 (2.1 %), V726A in 2 (2.1 %), P369S in 2 (2.1 %), R408Q in 2 (2.1 %), M694 V in 1 (1.1 %), respectively. Three patients were identified with compound heterozygosity. Distribution of MEFV gene mutations carriage in healthy controls was; E148Q in 11 (10.7 %), M694 V in 2 (1.9 %), M694I in 1 (0.9 %), M680I in 2 (1.9 %), V726A in 1 (0.9 %), A744S in 1 (0.9 %), K695R in 2 (1.9 %), and P369S in 1 (0.9 %) patients, respectively. Higher MEFV gene mutations carrier frequency was observed in patients with gouty arthritis, compared with the control group (p = 0.009). Heterozygous R202Q was the most common mutation detected in patients with gouty arthritis, while heterozygous E148Q in healthy control group. Statistically significant difference was not detected between clinical findings of gouty arthritis and the MEFV gene mutations (p > 0.05). We determined higher prevalence of MEFV gene mutations in patients with gouty arthritis compared with the healthy control group. The most frequently detected mutation was heterozygous R202Q, whereas E148Q in healthy controls. High carriage rates of MEFV gene mutations in gouty arthritis suggest that it may play an important role in the pathogenesis of the disease and predisposition to the disease.

Entities:  

Keywords:  Gouty arthritis; MEFV mutations; Prevalence

Mesh:

Substances:

Year:  2016        PMID: 27587294     DOI: 10.1007/s00296-016-3560-x

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  25 in total

1.  The significance of paired MEFV mutations in individuals without symptoms of familial Mediterranean fever.

Authors:  Mehmet Tunca; Servet Akar; Philip N Hawkins; Susanne E Booth; Bülent Sengül; Tugba Ulaş Yavuzşen; Selda Oktem; Müjde Soytürk; Nurullah Akkoç; David R Booth
Journal:  Eur J Hum Genet       Date:  2002-12       Impact factor: 4.246

2.  The familial Mediterranean fever (MEVF) gene as a modifier of Crohn's disease.

Authors:  Herma Fidder; Yehuda Chowers; Zvi Ackerman; Rivka Dresner Pollak; J Bart A Crusius; Avi Livneh; Simon Bar-Meir; Benjamin Avidan; Yael Shinhar
Journal:  Am J Gastroenterol       Date:  2005-02       Impact factor: 10.864

Review 3.  The role of interleukin-1 and the inflammasome in gout: implications for therapy.

Authors:  Richard M Pope; Jürg Tschopp
Journal:  Arthritis Rheum       Date:  2007-10

4.  The prevalence of familial Mediterranean fever in the Turkish province of Denizli: a field study with a zero patient design.

Authors:  V Cobankara; G Fidan; T Türk; M Zencir; M Colakoglu; S Ozen
Journal:  Clin Exp Rheumatol       Date:  2004 Jul-Aug       Impact factor: 4.473

5.  Association of familial Mediterranean fever-related MEFV variations with ankylosing spondylitis.

Authors:  Fulya Cosan; Duran Ustek; Basar Oku; Julide Duymaz-Tozkir; Aris Cakiris; Neslihan Abaci; Lale Ocal; Orhan Aral; Ahmet Gül
Journal:  Arthritis Rheum       Date:  2010-11

6.  MEFV mutations are increased in Behçet's disease (BD) and are associated with vascular involvement.

Authors:  P Atagunduz; T Ergun; H Direskeneli
Journal:  Clin Exp Rheumatol       Date:  2003 Jul-Aug       Impact factor: 4.473

7.  A variant allele of the Mediterranean-fever gene increases the severity of gout.

Authors:  Ayse Balkarli; Emre Tepeli; Huseyin Balkarli; Arif Kaya; Veli Cobankara
Journal:  Int J Rheum Dis       Date:  2016-04-29       Impact factor: 2.454

8.  MEFV mutations in patients with familial Mediterranean fever in the Black Sea region of Turkey: Samsun experience [corrected].

Authors:  Serbulent Yigit; Hasan Bagci; Ozan Ozkaya; Kazim Ozdamar; Kuddusi Cengiz; Tekin Akpolat
Journal:  J Rheumatol       Date:  2007-12-01       Impact factor: 4.666

9.  Inflammatory/demyelinating central nervous system involvement in familial Mediterranean fever (FMF): coincidence or association?

Authors:  G Akman-Demir; A Gul; E Gurol; H Ozdogan; S Bahar; A E Oge; H Gurvit; G Saruhan-Direskeneli; H Yazici; M Eraksoy
Journal:  J Neurol       Date:  2006-03-06       Impact factor: 4.849

10.  Mutations/polymorphisms in a monogenetic autoinflammatory disease may be susceptibility markers for certain rheumatic diseases: lessons from the bedside for the benchside.

Authors:  S Ozen
Journal:  Clin Exp Rheumatol       Date:  2009 Mar-Apr       Impact factor: 4.473

View more
  2 in total

Review 1.  Autoinflammatory Features in Gouty Arthritis.

Authors:  Paola Galozzi; Sara Bindoli; Andrea Doria; Francesca Oliviero; Paolo Sfriso
Journal:  J Clin Med       Date:  2021-04-26       Impact factor: 4.241

2.  Familial Mediterranean Fever Gene Mutations and Gout as an Auto-Inflammatory Arthropathy.

Authors:  Farhad Salehzadeh; Yusef Mohammadikebar; Roghayeh Nematdoust Haghi; Saeid Hosseini Asl; Afsaneh Enteshary
Journal:  Med Arch       Date:  2019-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.